Dipyridamole, an anti-platelet agent, reduces the vascular endothelial cell injury induced by active oxygen species

Y. Wakabayashi, H. Fujita, Keiji Fujimoto, H. Kawaguchi, I. Morita, S. Murota

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effects of the anti-platelet agent dipyridamole on vascular endothelial cells were assessed by measurement of the injury index induced by oxygen stress. Vascular endothelial cell injury was assayed by measuring 51Cr release from labeled vascular endothelial cells. Leukocytes activated by phorbol 12-myristate 13-acetate (PMA) were used to induce the injury of endothelial cells. In this system, dipyridamole suppressed endothelial cell injury in a dose dependent manner (0.1-10 4mUM) while it had no effect on production of superoxide anion in PMA-activated leukocytes. Treatment of endothelial cells with hydrogen peroxide also induced endothelial cell injury in a dose dependent manner (50-150 μM). Dipyridamole also prevented the endothelial cell injury induced by hydrogen peroxide with a dose dependent fashion (1-10 μM). There were no significant changes in the activities of catalyzing enzymes such as catalase and glutathione peroxidase in the endothelial cells following dipyridamole treatment. In contrast, dipyridamole significantly increased the cyclic GMP content of endothelial cells in a dose dependent manner (1-10 μM). Addition of 8-bromo-cyclic GMP (1 mM) to the culture also protected endothelial cells from injury induced by hydrogen peroxide, but 8-bromo-cyclic AMP did not. These data suggest that the protective effect of dipyridamole against oxygen stress is correlated with the increase in the cyclic GMP content of the endothelial cells.

Original languageEnglish
Pages (from-to)176-182
Number of pages7
JournalPlatelets
Volume6
Issue number3
DOIs
Publication statusPublished - 1995

Fingerprint

Dipyridamole
Reactive Oxygen Species
Blood Platelets
Endothelial Cells
Wounds and Injuries
Hydrogen Peroxide
Cyclic GMP
Acetates
Leukocytes
Oxygen
8-Bromo Cyclic Adenosine Monophosphate
Glutathione Peroxidase
Superoxides
Catalase

ASJC Scopus subject areas

  • Hematology
  • Cell Biology

Cite this

Dipyridamole, an anti-platelet agent, reduces the vascular endothelial cell injury induced by active oxygen species. / Wakabayashi, Y.; Fujita, H.; Fujimoto, Keiji; Kawaguchi, H.; Morita, I.; Murota, S.

In: Platelets, Vol. 6, No. 3, 1995, p. 176-182.

Research output: Contribution to journalArticle

Wakabayashi, Y. ; Fujita, H. ; Fujimoto, Keiji ; Kawaguchi, H. ; Morita, I. ; Murota, S. / Dipyridamole, an anti-platelet agent, reduces the vascular endothelial cell injury induced by active oxygen species. In: Platelets. 1995 ; Vol. 6, No. 3. pp. 176-182.
@article{edd164a032ab4a1ebaffb0e9445d3a1e,
title = "Dipyridamole, an anti-platelet agent, reduces the vascular endothelial cell injury induced by active oxygen species",
abstract = "The effects of the anti-platelet agent dipyridamole on vascular endothelial cells were assessed by measurement of the injury index induced by oxygen stress. Vascular endothelial cell injury was assayed by measuring 51Cr release from labeled vascular endothelial cells. Leukocytes activated by phorbol 12-myristate 13-acetate (PMA) were used to induce the injury of endothelial cells. In this system, dipyridamole suppressed endothelial cell injury in a dose dependent manner (0.1-10 4mUM) while it had no effect on production of superoxide anion in PMA-activated leukocytes. Treatment of endothelial cells with hydrogen peroxide also induced endothelial cell injury in a dose dependent manner (50-150 μM). Dipyridamole also prevented the endothelial cell injury induced by hydrogen peroxide with a dose dependent fashion (1-10 μM). There were no significant changes in the activities of catalyzing enzymes such as catalase and glutathione peroxidase in the endothelial cells following dipyridamole treatment. In contrast, dipyridamole significantly increased the cyclic GMP content of endothelial cells in a dose dependent manner (1-10 μM). Addition of 8-bromo-cyclic GMP (1 mM) to the culture also protected endothelial cells from injury induced by hydrogen peroxide, but 8-bromo-cyclic AMP did not. These data suggest that the protective effect of dipyridamole against oxygen stress is correlated with the increase in the cyclic GMP content of the endothelial cells.",
author = "Y. Wakabayashi and H. Fujita and Keiji Fujimoto and H. Kawaguchi and I. Morita and S. Murota",
year = "1995",
doi = "10.3109/09537109509013271",
language = "English",
volume = "6",
pages = "176--182",
journal = "Platelets",
issn = "0953-7104",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Dipyridamole, an anti-platelet agent, reduces the vascular endothelial cell injury induced by active oxygen species

AU - Wakabayashi, Y.

AU - Fujita, H.

AU - Fujimoto, Keiji

AU - Kawaguchi, H.

AU - Morita, I.

AU - Murota, S.

PY - 1995

Y1 - 1995

N2 - The effects of the anti-platelet agent dipyridamole on vascular endothelial cells were assessed by measurement of the injury index induced by oxygen stress. Vascular endothelial cell injury was assayed by measuring 51Cr release from labeled vascular endothelial cells. Leukocytes activated by phorbol 12-myristate 13-acetate (PMA) were used to induce the injury of endothelial cells. In this system, dipyridamole suppressed endothelial cell injury in a dose dependent manner (0.1-10 4mUM) while it had no effect on production of superoxide anion in PMA-activated leukocytes. Treatment of endothelial cells with hydrogen peroxide also induced endothelial cell injury in a dose dependent manner (50-150 μM). Dipyridamole also prevented the endothelial cell injury induced by hydrogen peroxide with a dose dependent fashion (1-10 μM). There were no significant changes in the activities of catalyzing enzymes such as catalase and glutathione peroxidase in the endothelial cells following dipyridamole treatment. In contrast, dipyridamole significantly increased the cyclic GMP content of endothelial cells in a dose dependent manner (1-10 μM). Addition of 8-bromo-cyclic GMP (1 mM) to the culture also protected endothelial cells from injury induced by hydrogen peroxide, but 8-bromo-cyclic AMP did not. These data suggest that the protective effect of dipyridamole against oxygen stress is correlated with the increase in the cyclic GMP content of the endothelial cells.

AB - The effects of the anti-platelet agent dipyridamole on vascular endothelial cells were assessed by measurement of the injury index induced by oxygen stress. Vascular endothelial cell injury was assayed by measuring 51Cr release from labeled vascular endothelial cells. Leukocytes activated by phorbol 12-myristate 13-acetate (PMA) were used to induce the injury of endothelial cells. In this system, dipyridamole suppressed endothelial cell injury in a dose dependent manner (0.1-10 4mUM) while it had no effect on production of superoxide anion in PMA-activated leukocytes. Treatment of endothelial cells with hydrogen peroxide also induced endothelial cell injury in a dose dependent manner (50-150 μM). Dipyridamole also prevented the endothelial cell injury induced by hydrogen peroxide with a dose dependent fashion (1-10 μM). There were no significant changes in the activities of catalyzing enzymes such as catalase and glutathione peroxidase in the endothelial cells following dipyridamole treatment. In contrast, dipyridamole significantly increased the cyclic GMP content of endothelial cells in a dose dependent manner (1-10 μM). Addition of 8-bromo-cyclic GMP (1 mM) to the culture also protected endothelial cells from injury induced by hydrogen peroxide, but 8-bromo-cyclic AMP did not. These data suggest that the protective effect of dipyridamole against oxygen stress is correlated with the increase in the cyclic GMP content of the endothelial cells.

UR - http://www.scopus.com/inward/record.url?scp=0029075646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029075646&partnerID=8YFLogxK

U2 - 10.3109/09537109509013271

DO - 10.3109/09537109509013271

M3 - Article

AN - SCOPUS:0029075646

VL - 6

SP - 176

EP - 182

JO - Platelets

JF - Platelets

SN - 0953-7104

IS - 3

ER -